PL2035451T3 - Synteza peptydów insulinotropowych - Google Patents

Synteza peptydów insulinotropowych

Info

Publication number
PL2035451T3
PL2035451T3 PL07765481T PL07765481T PL2035451T3 PL 2035451 T3 PL2035451 T3 PL 2035451T3 PL 07765481 T PL07765481 T PL 07765481T PL 07765481 T PL07765481 T PL 07765481T PL 2035451 T3 PL2035451 T3 PL 2035451T3
Authority
PL
Poland
Prior art keywords
peptide synthesis
insulinotropic peptide
insulinotropic
synthesis
peptide
Prior art date
Application number
PL07765481T
Other languages
English (en)
Inventor
Lin Chen
Yeun-Kwei Han
Christopher R Roberts
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL2035451T3 publication Critical patent/PL2035451T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL07765481T 2006-06-23 2007-06-19 Synteza peptydów insulinotropowych PL2035451T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81591906P 2006-06-23 2006-06-23
PCT/EP2007/056052 WO2007147816A1 (en) 2006-06-23 2007-06-19 Insulinotropic peptide synthesis
EP07765481A EP2035451B1 (en) 2006-06-23 2007-06-19 Insulinotropic peptide synthesis

Publications (1)

Publication Number Publication Date
PL2035451T3 true PL2035451T3 (pl) 2010-08-31

Family

ID=38596729

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07765481T PL2035451T3 (pl) 2006-06-23 2007-06-19 Synteza peptydów insulinotropowych

Country Status (33)

Country Link
US (2) US20080004429A1 (pl)
EP (1) EP2035451B1 (pl)
JP (1) JP4537495B2 (pl)
KR (1) KR101087859B1 (pl)
CN (1) CN101563364B (pl)
AR (1) AR061604A1 (pl)
AT (1) ATE466881T1 (pl)
AU (1) AU2007263043B2 (pl)
BR (1) BRPI0713575A2 (pl)
CA (1) CA2654610C (pl)
CL (1) CL2007001835A1 (pl)
CR (1) CR10463A (pl)
CY (1) CY1110186T1 (pl)
DE (1) DE602007006310D1 (pl)
DK (1) DK2035451T3 (pl)
EC (1) ECSP088999A (pl)
ES (1) ES2341588T3 (pl)
HR (1) HRP20100302T1 (pl)
IL (1) IL195421A0 (pl)
MA (1) MA30530B1 (pl)
MX (1) MX2008015935A (pl)
MY (1) MY144608A (pl)
NO (1) NO20084863L (pl)
NZ (1) NZ573093A (pl)
PL (1) PL2035451T3 (pl)
PT (1) PT2035451E (pl)
RS (1) RS51281B (pl)
RU (1) RU2448978C2 (pl)
SI (1) SI2035451T1 (pl)
TW (1) TWI331155B (pl)
UA (1) UA96602C2 (pl)
WO (1) WO2007147816A1 (pl)
ZA (1) ZA200810072B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
WO2009074483A2 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20100317057A1 (en) * 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
EP2424888A2 (en) * 2009-05-01 2012-03-07 F. Hoffmann-La Roche AG Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20110313131A1 (en) 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
EP2788110B1 (en) * 2011-12-08 2018-10-17 Pentair Water Pool and Spa, Inc. Aquaculture system and method of operating a pump in such a system
ES2682253T3 (es) 2011-12-29 2018-09-19 Novo Nordisk A/S Dipéptido que comprende un aminoácido no proteogénico
CN104936610A (zh) 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
CN119060201A (zh) * 2018-03-09 2024-12-03 费森尤斯卡比有限公司 利拉鲁肽、索马鲁肽和glp-1的化学酶促合成
EP3762408A1 (en) 2018-03-09 2021-01-13 Enzypep B.V. Chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1
EP3864032B1 (en) * 2018-10-09 2022-11-30 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of glp-1 analogues
TWI799680B (zh) 2019-01-29 2023-04-21 美商美國禮來大藥廠 製備gip/glp1雙重促效劑之方法
TWI738260B (zh) * 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
US12269844B2 (en) 2019-03-25 2025-04-08 Scinopharm Taiwan, Ltd. Process for purifying semaglutide and liraglutide
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US20220324936A1 (en) * 2019-06-18 2022-10-13 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of glucagon
US20230406900A1 (en) * 2022-06-01 2023-12-21 Scinopharm Taiwan, Ltd. Process for preparing glucagon-like peptide-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
JPH11503454A (ja) * 1995-04-14 1999-03-26 ジ アドミニストレイターズ オブ ザ チューレン エデュケイショナル ファンド 成長ホルモン放出因子の類似体
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
WO2000034331A2 (en) * 1998-12-07 2000-06-15 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Analogues of glp-1
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP1701970A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support

Also Published As

Publication number Publication date
ZA200810072B (en) 2009-12-30
CN101563364A (zh) 2009-10-21
DE602007006310D1 (pl) 2010-06-17
IL195421A0 (en) 2011-08-01
CY1110186T1 (el) 2015-01-14
US20110213082A1 (en) 2011-09-01
KR20090023619A (ko) 2009-03-05
US20080004429A1 (en) 2008-01-03
RU2448978C2 (ru) 2012-04-27
NZ573093A (en) 2012-01-12
CN101563364B (zh) 2014-04-02
DK2035451T3 (da) 2010-06-07
ES2341588T3 (es) 2010-06-22
CR10463A (es) 2009-02-26
AU2007263043A1 (en) 2007-12-27
TW200811195A (en) 2008-03-01
NO20084863L (no) 2009-01-22
EP2035451A1 (en) 2009-03-18
MX2008015935A (es) 2009-01-13
WO2007147816A1 (en) 2007-12-27
ATE466881T1 (de) 2010-05-15
CL2007001835A1 (es) 2008-03-14
JP2009541257A (ja) 2009-11-26
KR101087859B1 (ko) 2011-11-30
CA2654610C (en) 2012-03-20
ECSP088999A (es) 2009-01-30
TWI331155B (en) 2010-10-01
SI2035451T1 (sl) 2010-06-30
AR061604A1 (es) 2008-09-10
PT2035451E (pt) 2010-06-09
AU2007263043B2 (en) 2012-11-29
CA2654610A1 (en) 2007-12-27
RS51281B (sr) 2010-12-31
MA30530B1 (fr) 2009-06-01
MY144608A (en) 2011-10-14
RU2009101969A (ru) 2010-07-27
EP2035451B1 (en) 2010-05-05
JP4537495B2 (ja) 2010-09-01
BRPI0713575A2 (pt) 2013-02-13
HRP20100302T1 (hr) 2010-06-30
UA96602C2 (ru) 2011-11-25

Similar Documents

Publication Publication Date Title
ZA200810072B (en) Insulinotropic peptide synthesis
ZA200810738B (en) Polypeptide
GB2451999B (en) Fuel synthesis
DE602007008470D1 (en) Off
PL1849352T3 (pl) Kombajn
EP2017283A4 (en) Peptides
PL2097841T3 (pl) Synteza wielomianów
GB0723712D0 (en) Peptides
EP2029448A4 (en) TRANSPORT APPARATUS
IL197979A0 (en) Method for peptide synthesis
EP2123666A4 (en) PEPTIDE
AU308591S (en) Buckle
EP2036918A4 (en) PEPTIDE DERIVATIVE
GB0703945D0 (en) Peptide
GB0618748D0 (en) Peptide
GB0623539D0 (en) Polypeptides
IL197675A0 (en) Peptides
GB0708529D0 (en) Peptide standards
GB0605774D0 (en) Peptide
HK1134830A (en) Insulinotropic peptide synthesis
GB0617408D0 (en) Fischer-tropsch synthesis
EP2041295A4 (en) PROCESS FOR ARBITRARY PEPTIDESYNTHESIS
GB0609666D0 (en) Synthesis
GB0622908D0 (en) Synthesis
GB0625176D0 (en) Peptides